These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8497171)

  • 1. [New prospects in the treatment of hemophilia. High-purity concentrates of factor VIII].
    Tusell Puigbert JM
    Med Clin (Barc); 1993 May; 100(17):655-8. PubMed ID: 8497171
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemophilia--an ancient disease with new problems and new solutions.
    Rogers JS; Ritchey AK
    W V Med J; 1992 Feb; 88(2):50-3. PubMed ID: 1557907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
    Yoshioka A
    Rinsho Ketsueki; 1988 May; 29(5):649-54. PubMed ID: 3145996
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
    Tanaka I; Shima N
    Rinsho Ketsueki; 2005 Feb; 46(2):91-8. PubMed ID: 16447701
    [No Abstract]   [Full Text] [Related]  

  • 5. Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor concentrates.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Mar; 36(9):121-4. PubMed ID: 3102937
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant factor VIII in hemophilia A: the Canadian experience.
    Blanchette VS
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia.
    White GC; McMillan CW; Kingdon HS; Shoemaker CB
    N Engl J Med; 1989 Jan; 320(3):166-70. PubMed ID: 2492083
    [No Abstract]   [Full Text] [Related]  

  • 8. High purity factor VIII and immune state in HIV.
    Nurs Stand; 1993 Oct 6-12; 8(3):17. PubMed ID: 8217692
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant factor VII.
    Ng SC
    Med J Malaysia; 1995 Dec; 50(4):425. PubMed ID: 8668070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
    Ikematsu S; Yorifuji H; Arai M; Fukutake K
    Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
    Mannucci PM
    Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].
    Veyckemans F
    Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019
    [No Abstract]   [Full Text] [Related]  

  • 13. Una conferencia de amnesia.
    Haas GJ
    Common Factor; 1995 Apr; (no 10):30. PubMed ID: 11362352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pemphigoid and acquired hemophilia].
    Lightburn E; Morand JJ; Graffin B; Molinier S; Raphenon G; Poullin P; Harlé JR; Chouc C
    Ann Dermatol Venereol; 2001 Nov; 128(11):1229-31. PubMed ID: 11908168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
    Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
    Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leads from the MMWR. Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor concentrates.
    JAMA; 1987 Apr; 257(13):1706, 1708-9. PubMed ID: 3820484
    [No Abstract]   [Full Text] [Related]  

  • 17. Future perspective for the treatment of hemophilia A.
    Laurian Y
    J Thromb Haemost; 2005 Jun; 3(6):1320-1. PubMed ID: 15946228
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitor challenges in the paediatric setting.
    Sieger L; Aledort L
    Haemophilia; 2006 Jan; 12(1):106-7. PubMed ID: 16409186
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changed distribution of hemophilia preparations diminishes the risks of infection transmission].
    Eklund LH
    Lakartidningen; 1990 Oct; 87(40):3196. PubMed ID: 2122141
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.